ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers

November 29, 1996

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

Burton Clinic Shit Down Seven Year After PAHO Report

August 2, 1985

CCOP Q&A, List Of Research Bases

September 10, 1982

NCI Evaluating PDQ Evaluation

September 1, 1989

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988